The global circulating tumor cells market is expected to grow at a CAGR of 8.5% during the forecast period from 2021 to 2030. The growth of this market can be attributed to the increasing incidence of cancer globally. The global cancer incidence is expected to increase from 14 million in 2020 to 22 million in 2030. This increase in the number of cases will lead to an increased demand for circulating tumor cells detection methods which will drive the growth of this market during the forecast period.
The global circulating tumor cells market has been segmented on the basis of type into CellSearch technology which includes CellSearch-based immunoassays such as CD45+, CD3+, CD19+, CD20+, CD34+; Circulating Tumor Cells technology which includes CyTOF-based immunoassays such as EpCAM+CD133+CD44+CD24-, EpCAM-CD133-CD44-CD24-, EpCAM+CD133+CD44-, EpCAM-CD133-CD44-, EpCAM+Epithelial Markers; CTCs technology which includes CyTOF based immunoassays such as Epithelial Markers; CSCs technology which includes CyTOF based immunoassays such as ALDH1A1+. On basis of application it has been segmented into breast cancer diagnosis & treatment; prostate cancer diagnosis & treatment; colorectal cancer diagnosis & treatment; lung cancer diagnosis & treatment cancers diagnosis & treatment. On basis of region it has been segmented into North America ; Latin America ; Europe ; Asia Pacific ; Middle East& Africa.
-CTCs and CSCs are the two types of cells that can cause cancer to spread.
-CTCs are tumor cells that have broken off from a tumor and traveled through the bloodstream or lymphatic system to other parts of the body.
-CSCs are tumor cells that have not left the original tumor site but still have the ability to divide and create new tumors.
-The number of CTCs in a person's blood is an indicator for how aggressive their cancer is, as well as how likely it is to spread.
-CTCs can be detected by looking for specific proteins on their surface, such as Epidermal Growth Factor Receptor (EGFR).
Industry Growth Insights published a new data on “Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market”. The research report is titled “Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market research by Types (CellSearch, Others, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs), By Applications (Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment, Lung Cancer Diagnosis and Treatment, Other Cancers Diagnosis and Treatment), By Players/Companies Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio, On-chip, YZY Bio, BioView, Fluidigm, Ikonisys, AdnaGen, IVDiagnostics, Miltenyi Biotec, ScreenCell, Silicon Biosystems, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Research Report
By Type
CellSearch, Others, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
By Application
Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment, Lung Cancer Diagnosis and Treatment, Other Cancers Diagnosis and Treatment
By Companies
Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio, On-chip, YZY Bio, BioView, Fluidigm, Ikonisys, AdnaGen, IVDiagnostics, Miltenyi Biotec, ScreenCell, Silicon Biosystems, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
242
Number of Tables & Figures
170
Customization Available
Yes, the report can be customized as per your need.
 and Cancer Stem Cells (CSCs) Industry Outlook.svg)
Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report Segments:
The global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) market is segmented on the basis of:
Types
CellSearch, Others, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Breast Cancer Diagnosis and Treatment, Prostate Cancer Diagnosis and Treatment, Colorectal Cancer Diagnosis and Treatment, Lung Cancer Diagnosis and Treatment, Other Cancers Diagnosis and Treatment
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Janssen
- Qiagen
- Advanced Cell Diagnostics
- ApoCell
- Biofluidica
- Clearbridge Biomedics
- CytoTrack
- Celsee
- Fluxion
- Gilupi
- Cynvenio
- On-chip
- YZY Bio
- BioView
- Fluidigm
- Ikonisys
- AdnaGen
- IVDiagnostics
- Miltenyi Biotec
- ScreenCell
- Silicon Biosystems
- Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
 and Cancer Stem Cells (CSCs) Market Overview.svg)
Highlights of The Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- CellSearch
- Others
- Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
- By Application:
- Breast Cancer Diagnosis and Treatment
- Prostate Cancer Diagnosis and Treatment
- Colorectal Cancer Diagnosis and Treatment
- Lung Cancer Diagnosis and Treatment
- Other Cancers Diagnosis and Treatment
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
 and Cancer Stem Cells (CSCs) Market Statistics.svg)
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Circulating tumor cells (CTCs) are cancerous cells that have spread from the original site of the tumor to other parts of the body. Cancer stem cells (CSCs) are a subset of CTCs that can divide and grow indefinitely, leading to tumors.
Some of the major companies in the circulating tumor cells (ctcs) and cancer stem cells (cscs) market are Janssen, Qiagen, Advanced Cell Diagnostics, ApoCell, Biofluidica, Clearbridge Biomedics, CytoTrack, Celsee, Fluxion, Gilupi, Cynvenio, On-chip, YZY Bio, BioView, Fluidigm, Ikonisys, AdnaGen, IVDiagnostics, Miltenyi Biotec, ScreenCell, Silicon Biosystems, Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs.
The circulating tumor cells (ctcs) and cancer stem cells (cscs) market is expected to grow at a compound annual growth rate of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market - Supply Chain
4.5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Forecast
4.5.1. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size (000 Units) and Y-o-Y Growth
4.5.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Absolute $ Opportunity
5. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Type
5.3.1. CellSearch
5.3.2. Others
5.3.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Application
6.3.1. Breast Cancer Diagnosis and Treatment
6.3.2. Prostate Cancer Diagnosis and Treatment
6.3.3. Colorectal Cancer Diagnosis and Treatment
6.3.4. Lung Cancer Diagnosis and Treatment
6.3.5. Other Cancers Diagnosis and Treatment
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand Share Forecast, 2019-2026
9. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Application
9.4.1. Breast Cancer Diagnosis and Treatment
9.4.2. Prostate Cancer Diagnosis and Treatment
9.4.3. Colorectal Cancer Diagnosis and Treatment
9.4.4. Lung Cancer Diagnosis and Treatment
9.4.5. Other Cancers Diagnosis and Treatment
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Type
9.7.1. CellSearch
9.7.2. Others
9.7.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand Share Forecast, 2019-2026
10. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Application
10.4.1. Breast Cancer Diagnosis and Treatment
10.4.2. Prostate Cancer Diagnosis and Treatment
10.4.3. Colorectal Cancer Diagnosis and Treatment
10.4.4. Lung Cancer Diagnosis and Treatment
10.4.5. Other Cancers Diagnosis and Treatment
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Type
10.7.1. CellSearch
10.7.2. Others
10.7.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand Share Forecast, 2019-2026
11. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Application
11.4.1. Breast Cancer Diagnosis and Treatment
11.4.2. Prostate Cancer Diagnosis and Treatment
11.4.3. Colorectal Cancer Dianosis and Treatment
11.4.4. Lung Cancer Diagnosis and Treatment
11.4.5. Other Cancers Diagnosis and Treatment
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Type
11.7.1. CellSearch
11.7.2. Others
11.7.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand Share, 2019-2026
12. Asia Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Application
12.4.1. Breast Cancer Diagnosis and Treatment
12.4.2. Prostate Cancer Diagnosis and Treatment
12.4.3. Colorectal Cancer Diagnosis and Treatment
12.4.4. Lung Cancer Diagnosis and Treatment
12.4.5. Other Cancers Diagnosis and Treatment
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Type
12.7.1. CellSearch
12.7.2. Others
12.7.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand Share, 2019-2026
13. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Application
13.4.1. Breast Cancer Diagnosis and Treatment
13.4.2. Prostate Cancer Diagnosis and Treatment
13.4.3. Colorectal Cancer Diagnosis and Treatment
13.4.4. Lung Cancer Diagnosis and Treatment
13.4.5. Other Cancers Diagnosis and Treatment
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market Size and Volume Forecast by Type
13.7.1. CellSearch
13.7.2. Others
13.7.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Market Share Analysis
14.2. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Distributors and Customers
14.3. Circulating Tumor Cells (CTCs) and Cancer Stem Cells (CSCs) Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Janssen
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Qiagen
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Advanced Cell Diagnostics
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ApoCell
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Biofluidica
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Clearbridge Biomedics
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CytoTrack
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Celsee
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Fluxion
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Gilupi
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Cynvenio
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. On-chip
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. YZY Bio
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. BioView
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Fluidigm
14.4.15.1. Overview
14.4.15.2. Financials
